Glioblastoma Multiforme (GBM) WHO Grade IV
2 clinical trials · Condition
◉ Watch Glioblastoma Multiforme (GBM) WHO Grade IV
| Record | Firm | Date |
|---|---|---|
| Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma (NCT07100730) | Telix Pharmaceuticals (Innovations) Pty Limited | 2025-11-02 |
| Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme (NCT01866449) | University of Ulm | 2013-10-01 |
Track Glioblastoma Multiforme (GBM) WHO Grade IV automatically
Every clearance here is in the API, with alerts when new ones post.